Neb, Holger
Judd, Leonie
Hintereder, Gudrun
Zacharowski, Kai
Meybohm, Patrick
Article History
First Online: 16 July 2018
Einhaltung ethischer Richtlinien
:
: K. Zacharowski department is receiving unrestricted educational grants from B. Braun Melsungen AG, Fresenius Kabi GmbH, CSL Behring GmbH and Vifor Pharma GmbH. In the past 3 years, K. Zacharowski has received honoraria or travel support for consulting or lecturing from the following companies: Abbott GmbH &Co KG, AesculapAkademie GmbH, AQAI GmbH, AstellasPharma GmbH, AstraZeneca GmbH, Aventis Pharma GmbH, B. Braun Melsungen AG, Baxter Deutschland GmbH, Biosyn GmbH, Biotest AG, Bristol-Myers Squibb GmbH, CSL Behring GmbH, Dr. F. KöhlerChemie GmbH, Dräger Medical GmbH, Essex Pharma GmbH, Fresenius Kabi GmbH, Fresenius Medical Care, Gambro Hospal GmbH, Gilead, GlaxoSmithKline GmbH, Grünenthal GmbH, Hamilton Medical AG, HCCM Consulting GmbH, Heinen+Löwenstein GmbH, Janssen-Cilag GmbH, med Update GmbH, Medivance EU B.V., MSD Sharp&Dohme GmbH, Novartis Pharma GmbH, Novo Nordisk Pharma GmbH, P. J. Dahlhausen&Co. GmbH, Pfizer Pharma GmbH, Pulsion Medical Systems S.E., Siemens Healthcare, Teflex Medical GmbH, Teva GmbH, TopMedMedizintechnik GmbH, Verathon Medical, ViforPharma GmbH. P. Meybohm received research grants from the German Research Foundation (ME 3559/1-1, ME 3559/3-1), International Anesthesia Research Society, German Society of Anaesthesiology and Intensive Care Medicine, European Society of Anaesthesiology, grants by B. Braun Melsungen, CSL Behring, Fresenius Kabi and Vifor Pharma for the implementation of Frankfurt‘s Patient Blood Management Program; by Pfizer for investigator-initiated trial; honoraria for scientific lectures from B. Braun Melsungen, Vifor Pharma, Ferring, CSL Behring, Heinen&Löwenstein, and Aesculap Academy. H. Neb, L. Judd und G. Hintereder geben an, dass kein Interessenkonflikt besteht.
: Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.